FALK, M., Zuzana HORÁKOVÁ, Markéta SVOBODOVÁ, Michal MASAŘÍK, O. KOPECNA, Jaromír GUMULEC, Martina RAUDENSKÁ, D. DEPES, A. BACIKOVA, I. FALKOVA and Hana BINKOVÁ. gamma H2AX/53BP1 foci as a potential pre-treatment marker of HNSCC tumors radiosensitivity - preliminary methodological study and discussion. The European Physical Journal D. NEW YORK: Springer Berlin Heidelberg, vol. 71, No 9, p. 1-7. ISSN 1434-6060. doi:10.1140/epjd/e2017-80073-2. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name gamma H2AX/53BP1 foci as a potential pre-treatment marker of HNSCC tumors radiosensitivity - preliminary methodological study and discussion
Authors FALK, M. (203 Czech Republic), Zuzana HORÁKOVÁ (203 Czech Republic, belonging to the institution), Markéta SVOBODOVÁ (203 Czech Republic, belonging to the institution), Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution), O. KOPECNA (203 Czech Republic), Jaromír GUMULEC (203 Czech Republic, belonging to the institution), Martina RAUDENSKÁ (203 Czech Republic, belonging to the institution), D. DEPES (203 Czech Republic), A. BACIKOVA (203 Czech Republic), I. FALKOVA (203 Czech Republic) and Hana BINKOVÁ (203 Czech Republic, belonging to the institution).
Edition The European Physical Journal D, NEW YORK, Springer Berlin Heidelberg, 2017, 1434-6060.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10306 Optics
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.393
RIV identification code RIV/00216224:14110/17:00095036
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1140/epjd/e2017-80073-2
UT WoS 000411083200015
Keywords in English HNSCC tumor
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 18/4/2018 12:12.
Abstract
In order to improve patients' post-treatment quality of life, a shift from surgery to non-surgical (chemo) radio-treatment is recognized in head and neck oncology. However, about half of HNSCC tumors are resistant to irradiation and an efficient marker of individual tumor radiosensitivity is still missing. We analyzed whether various parameters of DNA double strand break (DSB) repair determined in vitro can predict, prior to clinical treatment initiation, the radiosensitivity of tumors. We compared formation and decrease of gamma H2AX/53BP1 foci in 48 h after irradiating tumor cell primocultures with 2 Gy of gamma-rays. To better understand complex tumor behavior, three different cell type primocultures - CD90(-), CD90(+), and a mixed culture of these cells - were isolated from 1 clinically radioresistant, 2 radiosensitive, and 4 undetermined HPV-HNSCC tumors and followed separately. While DSB repair was delayed and the number of persisting DSBs increased in the radiosensitive tumors, the results for the radioresistant tumor were similar to cultured normal human skin fibroblasts. Hence, DSB repair kinetics/efficiency may correlate with clinical response to radiotherapy for a subset of HNSCC tumors but the size (and therefore practical relevance) of this subset remains to be determined. The same is true for contribution of different cell type primocultures to tumor radioresistance.
Links
GA16-12454S, research and development projectName: Charakterizace a modifikace komplexní odpovědi buněk nádorů hlavy a krku na různá záření - krok kupředu ke kombinované personalizované (radio)terapii
Investor: Czech Science Foundation
PrintDisplayed: 19/4/2024 07:13